ICS 2019 Scientific Podium Short Oral Session S8

Speakers
	Scientific Podium Short Oral Session S8
	Wednesday 4th September 2019
	14:30 - 16:00
	Hall K Capacity: 1500
	Lunch provided
D David Castro-Diaz ICS Chair M Magnus Fall ICS Chair
Professional interest
Urology

14:30

#179 12 month patient reported outcomes of a fully-implanted, nickel sized and shaped tibial nerve stimulator for the treatment of overactive bladder syndrome with urgency urinary incontinence
Best in Category Prize: Overactive Bladder

Presenter: Sharon English

English S¹, Lucente V², Kaaki B³, Gilling P⁴, Meffan P⁵, Clark M⁶, Sand P⁷, Sen S⁸, Rovner E⁹, MacDiarmid S¹⁰
1.Canterbury Urology Research Trust, Christchurch, New Zealand, 2.Institute for Female Pelvic Medicine & Reconstructive Surgery, Allentown, Pennsylvania, USA, 3.Unity Point Health, Waterloo, Iowa, USA, 4.Tauranga Urology Research Ltd, Tauranga, New Zealand, 5.Roundhay Medical Centre, Nelson, New Zealand, 6.The Clark Center for Urogynecology, Newport Beach, California, USA, 7.Northshore University Health System, Skokie, Illinois, USA, 8.Stanford University, Stanford, California, USA, 9.Medical University of South Carolina, Charleston, South Carolina, 10.Alliance Urology Specialists, Greensboro, North Carolina, USA
Clinical Trial, Overactive Bladder, Urgency Urinary Incontinence, Quality of Life (QoL), New Devices

14:37

#180 Efficacy of vibegron, a novel selective β3-adrenoreceptor agonist, on urgency urinary incontinence with overactive bladder: Post-hoc analysis of phase III study

Presenter: Masaki Yoshida

Yoshida M¹, Takeda M², Gotoh M³, Yokoyama O⁴, Kakizaki H⁵, Takahashi S⁶, Masumori N⁷, Nagai S⁸, Hashimoto K⁸, Minemura K⁸
1.Department of Urology, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan, 2.Department of Urology, Graduate School of Medical Sciences, University of Yamanashi, Kofu, Yamanashi, Japan, 3.Department of Urology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan, 4.Department of Urology, Faculty of Medical Science, University of Fukui, Fukui, Japan, 5.Department of Renal and Urologic Surgery, Asahikawa Medical University, Asahikawa, Hokkaido, Japan, 6.Department of Urology, Nihon University School of Medicine, Tokyo, Japan, 7.Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan, 8.Kyorin Pharmaceutical Co., LTD, Tokyo, Japan
Overactive Bladder, Urgency Urinary Incontinence, Urgency/Frequency, Incontinence

14:45

#181 Once-Daily Vibegron 75 mg Demonstrates Statistically Significant Benefits on Key Secondary Endpoints Including Quality of Life in Patients With OAB: Data From an International Phase 3 Trial (EMPOWUR)

Presenter: David Staskin

Staskin D¹, Varano S², Frankel J³, Shortino D⁴, Jankowich R⁴, Mudd Jr P⁴
1.Tufts University School of Medicine, Boston, MA, 2.Clinical Research Consulting, Milford, CT, 3.Seattle Urology Research Center, Seattle, WA, 4.Urovant Sciences, Inc., Irvine, CA
Urgency Urinary Incontinence, Urgency/Frequency, Overactive Bladder

14:52

#182 12 YEAR SINGLE CENTER RETROSPECTIVE REVIEW OF RATE AND RISK FACTORS OF TINED LEAD BREAKAGE DURING SACRAL NEUROMODULATION LEAD EXPLANT

Presenter: Howard Goldman

Rueb J¹, Pizarro-Berdichevsky J², Derisaviford S¹, Goldman H¹
1.Cleveland Clinic, 2.Hospital Dr. Sotero del Rio, Department of Obstetricia y Ginecologia, Pontificia Universidad Catolica de Chile, Santiago, Chile
Retrospective Study, Neuromodulation, Surgery

15:00

#183 Response and cognitive safety of fesoterodine in patients >65y old with OAB. Is there a relationship between cognition and treatment response?

Presenter: Adrian Wagg

Wagg A¹, Elsobky M², Carlsson M³, Fernet M²
1.University of Alberta, 2.Pfizer Canada, 3.Pfizer Corp
Overactive Bladder, Gerontology, Retrospective Study

15:07

#184 Double blind, placebo-controlled trial of antibiotics in women with refractory Detrusor Overactivity: Effect on urge incontinence and quality of life.

Presenter: Kate H Moore

Moore K¹, Mansfield K², Chen Z¹, Allen W¹, Parkin K¹, Gebski V³
1.Department of Urogynaecology, University of New South Wales at St. George Hospital, Kogarah NSW 2217, Australia., 2.Illawara Health and Medical Research Institute, School of Medicine, University of Wollongong, Wollongong NSW 2522, Australia., 3.NHMRC Clincial Trials Centre, University of Sydney, Sydney, NSW 2522, Australia
Detrusor Overactivity, Pad Test, Clinical Trial, Infection, Urinary Tract, Urgency Urinary Incontinence

15:15

#185 Continuous Intravesical Delivery of Trospium Chloride Significantly Improves OAB Symptoms: Results of a Phase 1b Study

Presenter: Christopher Cutie

Cutie C¹, Efros M², Sobol J³, Gilleran J⁴, Maffeo J¹, Kennelly M⁵
1.TARIS Biomedical LLC, 2.AccuMed Research Associates, 3.Michigan Institute of Urology, 4.William Beaumont Hospital, 5.McKay Urology
Clinical Trial, Urgency Urinary Incontinence, Overactive Bladder, Quality of Life (QoL)

15:22

#186 Treatment of Overative Bladder with a Peritrigonal Injection Paradigm of OnabotulinumtoxinA is Associated with a Low Incidence of Clean Intermittent Catheterization

Presenter: Scott MacDiarmid

MacDiarmid S¹, Glazier D², Shapiro A³, McCrery R⁴, Jarnagin B⁵, Boroujerdi A⁶, Bai Z⁶, Gao G⁶, Patel A⁶, McCammon K⁷
1.Alliance Urology Specialists, 2.Virginia Urology, 3.Chesapeake Urology, 4.Adult Pediatric Urology & Urogynecology, PC, 5.Center for Pelvic Health, 6.Allergan plc, 7.Eastern Virginia Medical School
Clinical Trial, Incontinence, Overactive Bladder, Neuromodulation, Pharmacology

15:30

#187 The OAB Patient's Pathway: Is It a Long and Bumpy Road? A Quantitative Analysis.

Presenter: Lambertus P W Witte

Witte L¹, Elburg R², Hollegien L¹, Blanker M²
1.Isala Clinics, Zwolle, the Netherlands, 2.University Medical Center Groningen, the Netherlands
Conservative Treatment, Overactive Bladder, Urgency Urinary Incontinence, Urgency/Frequency, Female

15:37

#188 Will detrusor overactivity progress to detrusor underactivity? A longitudinal long-term urodynamic follow-up in patients with overactive bladder syndrome

Presenter: Sheng-Fu Chen

Chen S¹, Jiang Y¹, Ping-Jui L¹, Kuo H¹
1.Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan
Nocturia, Detrusor Overactivity, Bladder Outlet Obstruction

15:45

#189 Long-term follow-up of intravesical onabotulinum toxin-A injections in male patients with idiopathic OAB: the role of prostate surgery

Presenter: Julia Bels

Bels J¹, Marcelissen T², De Beij J¹, De Vries P¹, Rademakers K¹
1.Zuyderland MC, 2.Maastricht Universitair Medisch Centrum
Overactive Bladder, Benign Prostatic Hyperplasia (BPH), Male, Retrospective Study, Incontinence

15:52

#190 MANAGEMENT OF PATIENTS WITH OVERACTIVE BLADDER WHO FAIL INTRADETRUSOR ONABOTULINUMTOXINA INJECTIONS: WHAT HAPPENS NEXT?

Presenter: Howard Goldman

Zahner P¹, Giusto L¹, Derisavifard S¹, Rueb J¹, Courtenay M¹, Rackley R¹, Vasavada S¹, Goldman H¹
1.Cleveland Clinic Foundation
Detrusor Overactivity, Overactive Bladder, Retrospective Study, Urgency Urinary Incontinence, Incontinence

Content Visitors (staff only)

Overactive Bladder

Session Schedule

Comments

Chat